Literature DB >> 7922049

Relationship between weight loss, reduction of body cell mass and inflammatory response in patients with cancer.

D C McMillan1, T Preston, W S Watson, J M Simpson, K C Fearon, A Shenkin, H J Burns, C S McArdle.   

Abstract

Reduced food intake is a major cause of continuing weight loss in patients with cancer. Previous work has suggested that an ongoing inflammatory response may also contribute to weight loss and alter the nature of body tissue loss. To examine this, body cell mass was estimated using measurements of total body potassium (TBK) in 31 patients with gastrointestinal cancer and weight loss with or without an inflammatory response (C-reactive protein level above 5 mg/l). Albumin levels, total body water and 24-h urinary creatinine clearance were also measured. When measured TBK was expressed as a percentage of predicted normal values there was a significant reduction in TBK for patients with an inflammatory response compared with that of those without (P = 0.04). However, when a different prediction equation for TBK was used this difference was not significant (P = 0.29). Therefore, it remains uncertain whether an ongoing inflammatory response in patients with cancer and weight loss contributes to loss of body cell mass.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7922049     DOI: 10.1002/bjs.1800810727

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  6 in total

Review 1.  Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate?

Authors:  Bassel Nazha; Elias Moussaly; Mazen Zaarour; Chanudi Weerasinghe; Basem Azab
Journal:  World J Gastrointest Surg       Date:  2015-12-27

2.  A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss.

Authors:  D C McMillan; S J Wigmore; K C Fearon; P O'Gorman; C E Wright; C S McArdle
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

3.  Prediction of Hepatocellular Carcinoma Prognosis and Immune Cell Infiltration Using Gene Signature Associated with Inflammatory Response.

Authors:  Bin-Bin Da; Shuai Luo; Ming Huang; Fei Song; Rong Ding; Yao Xiao; Yang Fu; Yin-Shan Yang; Hai-Lei Wang
Journal:  Comput Math Methods Med       Date:  2022-01-07       Impact factor: 2.238

Review 4.  Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-Analysis.

Authors:  Xiao-Dong Sun; Xiao-Ju Shi; Yu-Guo Chen; Chuan-Lei Wang; Qiang Ma; Guo-Yue Lv
Journal:  Gastroenterol Res Pract       Date:  2015-12-30       Impact factor: 2.260

5.  A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart.

Authors:  Valentina Sala; Stefano Gatti; Simona Gallo; Enzo Medico; Daniela Cantarella; James Cimino; Antonio Ponzetto; Tiziana Crepaldi
Journal:  Biomed Res Int       Date:  2016-05-19       Impact factor: 3.411

Review 6.  Pancreas Cancer-Associated Weight Loss.

Authors:  Andrew E Hendifar; Maria Q B Petzel; Teresa A Zimmers; Crystal S Denlinger; Lynn M Matrisian; Vincent J Picozzi; Lola Rahib
Journal:  Oncologist       Date:  2018-12-27       Impact factor: 5.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.